News
EFCG welcomes the European Parliament’s Commitment to a Strong Critical Medicines Act
The European Fine Chemicals Group (EFCG) welcomes the European Parliament’s position on the Critical Medicines Act (CMA), a landmark initiative aimed at strengthening Europe’s health security and...
Read moreThe Strategic Role of CDMOs in Europe’s Biopharmaceuticals future
EFCG calls on policymakers to decisively imbed Contract Development and Manufacturing Organizations (CDMOs) within the Biotech Act’s implementation roadmap. This is essential to secure Europe’s le...
Read moreArticle in Chemistry Today – Chimica Oggi
In the past three years, EFCG relentlessly strove to alert EU authorities on the need to address head-on the root causes of the supply tensions and shortages that are affecting Europe’s supply of...
Read moreA STRONG EUROPEAN API INDUSTRY CAN ACHIEVE STRATEGIC AUTONOMY OF THE EU HEALTH SYSTEM
Europe needs a strong EU-based API industry to achieve strategic autonomy for its health system. EFCG - MfE Joint paper Unique-APIs Nov 8, 2022 The COVID-19 pandemic highlighted the vulnerabilit...
Read more
Register now to the CPhI webinar on excipients
The CPhI is organising a - free - webinar on Why the Excipients Market Needs to Embrace the New Normal. When? On 31 August at 4pm CET/10am EST. More info and registrations here...
Read more
Register to the CPhI webinar on 26th January
Our EFCG Vice-President Gildas Barreyre (General Secretary, SEQENS) and Dirkjan van Zoelen (Manager Development and Technical Support, Aspen Oss B.V), EFCG members, will speak at the CPhI webinar....
Read more